Mirtazapine overdose: A case report

Medical Update for Psychiatrists

Volumn 2, Issue 2, 1997, Pages 58-59

  Kao, Louise ^a   Barkin, Robert L ^a   Leikin, Jerrold B ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006567285     PISSN: 10827579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1082-7579(97)00012-5     Document Type: Article

References (10)

1. 2 selective adrenoceptor antagonist Org 337 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission. Human Psychopharmacol 1995; 10 (suppl 2) :S107-18.
2. 1A-mediated serotonergic neuro-transmission. CNS Drugs 1995; 4:29-38.
3. de Montigny C, Haddjeri N, Mongeau R, Blier P. The effects of mirtazapine on the interactions between central noradrenergic and serotonergic systems. CNS Drugs 1995;4(suppl 1):13-7.
4. Timmer CJ, Lohmann AAM, Mink CPA. Pharmacokinetic dose-proportionality study at steady state of mirtazapine from Remeron® tablets. Human Psychopharmacol 1995;10(suppl 2):S97-106.
5. REMERON™ (mirtazapine) Prescribing Information; Organon, Inc, West Orange, New Jersey.
6. Voortman G, Paanakker JE. Bioavailability of mirtazapine from Remeron® tablets after single and multiple oral dosing. Human Psychopharmacol 1995; 10 (suppl 2) : S893-6.
7. Claghorn JL, Lesem MD. A double-blind placebo-controlled study of Org 3770 in depressed outpatients. J Affective Disord 1995;34:165-71.
8. Bremner JD. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression. J Clin Psychiatry 1995;56:519-25.
9. Smith WT, Glaudin V, Panagides J, Gilvary E. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Psychopharmacol Bull 1990;26(2): 191-6.
10. Ruigt GSF, Kemp B, Groenhout CM, Kamphuisen HAC. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 1990;38:551-4.